These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 3632718)
21. SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile. Aubin N; Barneoud P; Carter C; Caille D; Sontag N; Marc C; Lolivier J; Gardes A; Perron C; Le Kim A; Charieras T; Pandini M; Burnier P; Puech F; Jegham S; George P; Scatton B; Curet O J Pharmacol Exp Ther; 2004 Sep; 310(3):1171-82. PubMed ID: 15178694 [TBL] [Abstract][Full Text] [Related]
22. [Kinetic characteristics of monoamine oxidase in brain regions of animals with varying degrees of sensitivity to 1-methyl, 4-phenyl, 1,2,3,6- tetrahydropyridine]. Ishkov AG; Ermakov NV; Mikerov SV; Miroshnichenko EV Vopr Med Khim; 1991; 37(5):49-52. PubMed ID: 1759397 [TBL] [Abstract][Full Text] [Related]
23. Modification of dopamine release by selective inhibitors of MAO-B. Finberg JP; Lamensdorf I; Armoni T Neurobiology (Bp); 2000; 8(2):137-42. PubMed ID: 11061211 [TBL] [Abstract][Full Text] [Related]
24. The oxidation of dopamine and epinine by the two forms of monoamine oxidase from rat liver. Strolin Benedetti M; Sanson G; Bona L; Gallina M; Persiani S; Tipton KF J Neural Transm Suppl; 1998; 52():233-8. PubMed ID: 9564622 [TBL] [Abstract][Full Text] [Related]
25. Ontogenesis of enzyme systems deaminating different monoamines. Blatchford D; Holzbauer M Br J Pharmacol; 1976 Jun; 57(2):279-93. PubMed ID: 938797 [TBL] [Abstract][Full Text] [Related]
26. Oxidation of N-methyl-1,2,3,4-tetrahydroisoquinoline into the N-methyl-isoquinolinium ion by monoamine oxidase. Naoi M; Matsuura S; Parvez H; Takahashi T; Hirata Y; Minami M; Nagatsu T J Neurochem; 1989 Feb; 52(2):653-5. PubMed ID: 2911035 [TBL] [Abstract][Full Text] [Related]
27. Localization of monoamine oxidases A and B in primate brains relative to neuron-specific and non-neuronal enolases. Campbell IC; Marangos PJ; Parma A; Garrick NA; Murphy DL Neurochem Res; 1982 Jun; 7(6):657-66. PubMed ID: 7121716 [TBL] [Abstract][Full Text] [Related]
28. Inhibition of Excessive Monoamine Oxidase A/B Activity Protects Against Stress-induced Neuronal Death in Huntington Disease. Ooi J; Hayden MR; Pouladi MA Mol Neurobiol; 2015 Dec; 52(3):1850-1861. PubMed ID: 25398695 [TBL] [Abstract][Full Text] [Related]
29. Correlation of MPTP neurotoxicity in vivo with oxidation of MPTP by the brain and blood-brain barrier in vitro in five rat strains. Riachi NJ; Behmand RA; Harik SI Brain Res; 1991 Jul; 555(1):19-24. PubMed ID: 1933326 [TBL] [Abstract][Full Text] [Related]
30. Postnatal development of dopamine deamination in the striatum of the rat. Davis AJ; Holzbauer M; Sharman DF Br J Pharmacol; 1975 Dec; 55(4):558-60. PubMed ID: 1212563 [TBL] [Abstract][Full Text] [Related]
31. The pharmacodynamic characterization of an antisense oligonucleotide against monoamine oxidase-B (MAO-B) in rat brain striatal tissue. Sprague JE; Worst TJ; Haynes K; Mosler CR; Nichols DE; Kane MD Cell Mol Neurobiol; 2001 Feb; 21(1):53-64. PubMed ID: 11440198 [TBL] [Abstract][Full Text] [Related]
32. Type A and B monoamine oxidase activities in the human and rat kidney. Fernandes MH; Soares-da-Silva P Acta Physiol Scand; 1992 Aug; 145(4):363-7. PubMed ID: 1529723 [TBL] [Abstract][Full Text] [Related]
33. In vivo effect of MPTP on monoamine oxidase activity in mouse striatum. Melamed E; Youdim MB; Rosenthal J; Spanier I; Uzzan A; Globus M Brain Res; 1985 Dec; 359(1-2):360-3. PubMed ID: 3878183 [TBL] [Abstract][Full Text] [Related]
34. Studies on the subcellular localization of monoamine oxidase types A and B and its importance for the deamination of dopamine in the rat brain. Urwyler S; von Wartburg JP Biochem Pharmacol; 1980 Nov; 29(22):3067-73. PubMed ID: 6779822 [No Abstract] [Full Text] [Related]
35. Effect of plasma from premenstrual syndrome and control patients on human platelet and rat brain synaptosome monoamine oxidase B activity. Ashby CR; Carr LA; Cook C; Steptoe MM; Franks DD Neuropsychobiology; 1992; 25(3):121-5. PubMed ID: 1407477 [TBL] [Abstract][Full Text] [Related]
36. Dopamine-degrading activity of monoamine oxidase is not detected by histochemistry in neurons of the substantia nigra pars compacta of the rat. Arai R; Horiike K; Hasegawa Y Brain Res; 1998 Nov; 812(1-2):275-8. PubMed ID: 9813366 [TBL] [Abstract][Full Text] [Related]
37. Evidence for an extraneuronal location of monoamine oxidase in renal tissues. Caramona MM; Soares-da-Silva P Naunyn Schmiedebergs Arch Pharmacol; 1990 May; 341(5):411-3. PubMed ID: 2366877 [TBL] [Abstract][Full Text] [Related]
38. Monoamine oxidase-dependent metabolism of dopamine in the striatum and substantia nigra of L-DOPA-treated monkeys. Di Monte DA; DeLanney LE; Irwin I; Royland JE; Chan P; Jakowec MW; Langston JW Brain Res; 1996 Oct; 738(1):53-9. PubMed ID: 8949927 [TBL] [Abstract][Full Text] [Related]
39. Evidence for the localization of hydrogen peroxide-stimulated cyclooxygenase activity in rat brain mitochondria: a possible coupling with monoamine oxidase. Seregi A; Serfözö P; Mergl Z J Neurochem; 1983 Feb; 40(2):407-13. PubMed ID: 6401800 [TBL] [Abstract][Full Text] [Related]
40. Monoamine oxidase: distribution in the cat brain studied by enzyme- and immunohistochemistry: recent progress. Kitahama K; Maeda T; Denney RM; Jouvet M Prog Neurobiol; 1994 Jan; 42(1):53-78. PubMed ID: 7480787 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]